Morgan Stanley Daxor Corp Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Daxor Corp stock. As of the latest transaction made, Morgan Stanley holds 88 shares of DXR stock, worth $715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88
Previous 1
8700.0%
Holding current value
$715
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DXR
# of Institutions
11Shares Held
105KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.8KShares$396,9710.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny27.8KShares$226,1840.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL14.6KShares$118,7950.07% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ7.2KShares$58,5360.0% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M03.13KShares$25,4300.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $32.9M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...